UNSPSC 51131653: Ticlopidine

This classification denotes a thienopyridine antiplatelet agent with the molecular formula C14H14ClNS, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier OM90ZUW7M1, chemically known as 5-((2-chlorophenyl)methyl)-4,5,6,7-tetrahydrothieno(3,2-c)pyridine but generally known as ticlopidine, which bears US NIH Compound Identifier 5472. European Medicines Agency schedules Ticlopidine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB11028MIG.

UNSPSC 51131653 Ticlopidine is a Commodity code that shows a significant mismatch between its nominal scope—a antiplatelet pharmaceutical—and the recent state and local procurement activity tagged to it. The single recent opportunity on record is Sourcewell RFP #061626, a law enforcement equipment solicitation with a response deadline of June 16, 2026, which bears no relationship to pharmaceutical procurement. State and local governments use UNSPSC codes to classify goods and services they purchase, but this code's recent activity does not reflect pharmaceutical acquisitions or ticlopidine dispensing; the tagged opportunity instead addresses law enforcement equipment for thousands of governmental agencies, higher education institutions, school districts, nonprofit organizations, tribal governments, and other public entities across the United States and Canada.

The geographic scope of the Sourcewell RFP extends across multiple states, including Washington (where the solicitation is being advertised under RCW 39.34), Minnesota (Sourcewell's administrative home), and numerous other jurisdictions nationwide, suggesting broad multi-state participation through a cooperative purchasing vehicle. The mismatch between the code's pharmaceutical intent and the law enforcement equipment solicitation indicates that either the code was applied in error to the opportunity or the code sees little relevant recent activity in its intended commodity class. No other recent state or local pharmaceutical or ticlopidine-specific procurement opportunities appear in the source, and the single tagged record does not provide a reliable signal for business development under this code's nominal scope.